Justine Yang Bruce

11PUBLICATIONS
63CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer geneticsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 01, 2026
A Novel Syngeneic Mouse Model to Study Immune Evasion in Head and Neck Squamous Cell Carcinoma.

|May 05, 2026
Enfortumab vedotin plus pembrolizumab as first-line treatment in recurrent or metastatic head and neck squamous cell carcinoma: results from EV-202 cohort 9.

|Mar 28, 2025
Axl Regulation of NK Cell Activity Creates an Immunosuppressive Tumor Immune Microenvironment in Head and Neck Cancer.

Kourtney L Kostecki, Regan L Harmon, Mari Iida

|Feb 19, 2025
Reply to: Enfortumab Vedotin: A Promising Therapy for Head and Neck Cancer With Potential Links to Human Papillomavirus.

Paul L Swiecicki, Emrullah Yilmaz, Ari Joseph Rosenberg

|Oct 31, 2024
Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer.

Paul L Swiecicki, Emrullah Yilmaz, Ari Joseph Rosenberg

|Oct 26, 2024
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma.

Bridget E Crossman, Regan L Harmon, Kourtney L Kostecki

Pageof 2

Frequent Collaborators

5 joint publications

Mari Iida

5 joint publications

Ravi Salgia

4 joint publications

Kourtney L Kostecki

4 joint publications

Bridget E Crossman